SCHEMBL2909835

SCHEMBL2909835

C[C@H](O)CNC(=O)c1cn(CCCNc2ccc([N+](=O)[O-])c(N)n2)cc1-c1ccc(Cl)cc1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 5/20 0.48
GSK3A P49840 3/20 0.48
CDK1 P06493 2/20 0.44
CCNB2 O95067 1/20 0.43
CCNB1 P14635 1/20 0.43
CCNB3 Q8WWL7 1/20 0.43
ALDH1A1 P00352 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
LMNA P02545 2/20 0.37
CYP2C19 P33261 2/20 0.34
ACVR1B P36896 1/20 0.34
TGFBR1 P36897 1/20 0.34
ACVRL1 P37023 1/20 0.34
HPGD P15428 3/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
POLB P06746 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
ALPL P05186 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2912195 1.00 GSK3B (0.48) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2934514 0.98 GSK3B (0.47) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2904498 0.98 GSK3B (0.47) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2907739 0.93 GSK3B (0.42) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2911262 0.93 GSK3B (0.42) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2912584 0.93 GSK3B (0.40) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2913229 0.93 GSK3B (0.40) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL1216751 0.91 GSK3B (0.38) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2912135 0.91 GSK3B (0.38) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL12632071 0.91 GSK3B (0.38) GSK3BGSK3ACDK1CCNB2CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed